Optical Coherence Tomography in the Assessment and Management of Cardiac Allograft Vasculopathy
- PMID: 38864982
- DOI: 10.1007/s11886-024-02078-7
Optical Coherence Tomography in the Assessment and Management of Cardiac Allograft Vasculopathy
Abstract
Purpose of review: Cardiac Allograft vasculopathy (CAV) is a major barrier to improving outcomes after heart transplantation. Coronary angiography has very low sensitivity to detect early CAV and intravascular ultrasound (IVUS) only improves it to some extent. In this article, we detail the current evidence surrounding use of Optical Coherence tomography (OCT) in patients with CAV.
Recent findings: OCT has the ability to recognize CAV at earlier stages with intimal thickness < 150 μm, can characterize CAV in almost pathologic / microscopic detail - plaque characteristics are better visualized and novel early features such as layered fibrotic plaques and microchannels have been identified. Progression of CAV can be monitored also, with promise shown in automated serial measurements also. OCT has significantly advanced our understanding of the pathophysiology-as well as permits precise monitoring and surveillance of the disease. Potential treatment options could also be evaluated using OCT.
Keywords: Cardiac allograft vasculopathy; Optical coherence tomography.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.J Heart Lung Transplant. 2016 Jan;35(1):74-79. doi: 10.1016/j.healun.2015.08.011. Epub 2015 Sep 3. J Heart Lung Transplant. 2016. PMID: 26452998
-
Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.JACC Cardiovasc Imaging. 2017 Jul;10(7):773-784. doi: 10.1016/j.jcmg.2016.10.021. Epub 2017 Mar 15. JACC Cardiovasc Imaging. 2017. PMID: 28330670
-
Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness.Int Heart J. 2014;55(2):178-80. doi: 10.1536/ihj.13-279. Epub 2014 Mar 14. Int Heart J. 2014. PMID: 24632967
-
How to Approach the Assessment of Cardiac Allograft Vasculopathy in the Modern Era: Review of Invasive Imaging Modalities.Curr Heart Fail Rep. 2016 Apr;13(2):86-91. doi: 10.1007/s11897-016-0283-y. Curr Heart Fail Rep. 2016. PMID: 26879390 Review.
-
Clinical utility of intravascular ultrasound in the assessment of coronary allograft vasculopathy: a review.J Interv Cardiol. 2011 Feb;24(1):9-14. doi: 10.1111/j.1540-8183.2010.00600.x. Epub 2010 Oct 4. J Interv Cardiol. 2011. PMID: 21029179 Review.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
-
- Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019;38(10):1056–66. - DOI - PubMed - PMC
-
- Shahandeh N, Parikh RV. Invasive Intracoronary Imaging of Cardiac Allograft Vasculopathy: Established Modalities and Emerging Technologies. Interv Cardiol Clin. 2023;12(2):269–80. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials